+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin-induced muscular problems are underestimated



Statin-induced muscular problems are underestimated



Ugeskrift for Laeger 172(16): 1235; Author Reply 1235




(PDF emailed within 1 workday: $29.90)

Accession: 055911587

Download citation: RISBibTeXText

PMID: 20437666


Related references

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. British Journal of Clinical Pharmacology 57(4): 525-528, 2004

Statin-induced muscular symptoms: a report of 3 cases. Acta Orthopaedica Belgica 74(4): 569-572, 2008

The clinical and muscular pathological features of statin-induced myopathy. Zhonghua Nei Ke Za Zhi 54(8): 716-720, 2016

Statin discontinuation: an underestimated risk?. Current Medical Research and Opinion 24(11): 3059-3062, 2008

Managing the underestimated risk of statin-associated myopathy. International Journal of Cardiology 159(3): 169-176, 2013

Plasma membrane transporters in human muscular cells and their potential role in statin-induced toxicity.. 2008

Statin-related muscle complaints: an underestimated risk. Cardiovascular Drugs and Therapy 19(6): 379-381, 2006

Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum". Autoimmunity Reviews 12(12): 1177-1181, 2014

A systematic review of statin-induced muscle problems in clinical trials. American Heart Journal 168(1): 6-15, 2014

Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. Journal of Pharmacy Practice 30(5): 521-527, 2016

Urinary problems among patients with stroke. Are these problems underestimated?. Tidsskrift for den Norske Laegeforening 111(21): 2659-2662, 1991

Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocol. Biofactors 18(1-4): 125-127, 2003

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006. Plos One 3(6): E2522, 2008

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin. Molecular Diagnosis and Therapy 21(1): 95-105, 2016

Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin. Value in Health 18(7): A396, 2015